These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18471030)

  • 1. Optimal cancer care across the spectrum of life and disease.
    Lyman GH; Hauser RS
    Am J Manag Care; 2008 May; 14(5):262-4. PubMed ID: 18471030
    [No Abstract]   [Full Text] [Related]  

  • 2. Is high and growing spending on cancer treatment and prevention harmful to the United States economy?
    Pauly MV
    J Clin Oncol; 2007 Jan; 25(2):171-4. PubMed ID: 17210935
    [No Abstract]   [Full Text] [Related]  

  • 3. Managing oncology costs.
    Reeder CE; Gordon D
    Am J Manag Care; 2006 Feb; 12(1 Suppl):S3-16; quiz S17-9. PubMed ID: 16478368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating economic analysis into cancer clinical trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook.
    J Natl Cancer Inst Monogr; 1998; (24):1-28. PubMed ID: 9704318
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost of cancer care: issues and implications.
    Meropol NJ; Schulman KA
    J Clin Oncol; 2007 Jan; 25(2):180-6. PubMed ID: 17210937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Not at any cost: organizations help patients cope with costs of cancer care.
    Printz C
    Cancer; 2011 Mar; 117(5):879. PubMed ID: 21351079
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    Petrelli NJ; Winer EP; Brahmer J; Dubey S; Smith S; Thomas C; Vahdat LT; Obel J; Vogelzang N; Markman M; Sweetenham JW; Pfister D; Kris MG; Schuchter LM; Sawaya R; Raghavan D; Ganz PA; Kramer B
    J Clin Oncol; 2009 Dec; 27(35):6052-69. PubMed ID: 19901123
    [No Abstract]   [Full Text] [Related]  

  • 8. How should we pay the piper when he's calling the tune? On the long-term affordability of cancer care in the United States.
    Ramsey SD
    J Clin Oncol; 2007 Jan; 25(2):175-9. PubMed ID: 17210936
    [No Abstract]   [Full Text] [Related]  

  • 9. Can we afford the war on cancer?
    Szucs TD
    Onkologie; 2008 Mar; 31(3):81. PubMed ID: 18322408
    [No Abstract]   [Full Text] [Related]  

  • 10. The war on cancer: progress at what price?
    Konski A
    J Clin Oncol; 2011 Apr; 29(12):1503-4. PubMed ID: 21402613
    [No Abstract]   [Full Text] [Related]  

  • 11. Oncological resource allocation in Germany.
    Hartmann M; Kath R; Gundermann C
    Onkologie; 2008 Mar; 31(3):85-9. PubMed ID: 18322410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation in radiology: reviewing the literature and examples in oncology.
    Bresnahan BW
    Acad Radiol; 2010 Sep; 17(9):1090-5. PubMed ID: 20634104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palliative care programs still face obstacles in mainstream cancer care.
    Benowitz S
    J Natl Cancer Inst; 2013 Mar; 105(6):372-4. PubMed ID: 23457209
    [No Abstract]   [Full Text] [Related]  

  • 14. Affordable oncologic care: a challenging goal.
    Barton MK
    CA Cancer J Clin; 2014; 64(2):75-8. PubMed ID: 24420975
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost of cancer care: the patient perspective.
    Kim P
    J Clin Oncol; 2007 Jan; 25(2):228-32. PubMed ID: 17210945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case management: a tool for disease management programs.
    Kozma CM
    Manag Care Interface; 1999 Aug; 12(8):62, 64. PubMed ID: 10621095
    [No Abstract]   [Full Text] [Related]  

  • 17. Disease management. Decreasing cost and increasing patient satisfaction: the implementation of a cancer disease management program.
    Kirsh WD; Lee R
    Manag Care Interface; 1999 Aug; 12(8):65-8. PubMed ID: 10621096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost of treating cancer patients: treatments versus reimbursements.
    Goldstein MG
    Md Med; 2011; 12(4):15. PubMed ID: 22455202
    [No Abstract]   [Full Text] [Related]  

  • 19. Reporting and grading financial toxicity.
    Khera N
    J Clin Oncol; 2014 Oct; 32(29):3337-8. PubMed ID: 25199760
    [No Abstract]   [Full Text] [Related]  

  • 20. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.